CareLit · DOI-Nachweis · Pneumologie
Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing extents of lung fibrosis: the SENSCIS trial*
DOI 10.1055/s-0039-3403187
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Wiewrodt, G Raghu, O Distler, A Azuma, KB Highland, M Kuwana, MD Mayes, D Wachtlin, S Stowasser, M Alves, M Gahlemann, TM Maher
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing extents of lung fibrosis: the SENSCIS trial*
Zitieren
Zitierempfehlung
R Wiewrodt, G Raghu, O Distler, A Azuma, KB Highland, M Kuwana, MD Mayes, D Wachtlin, S Stowasser, M Alves, M Gahlemann, TM Maher (2020) Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing extents of lung fibrosis: the SENSCIS trial*. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403187
Mit CareLit weiterarbeiten